LEAD TECHNOLOGIES, INC. – Trademark Portfolio
Entity Type: 03
LEAD TECHNOLOGIES, INC. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include LEAD, MIPACS, LEADVIEW, LEADTOOLS, and MEDICOR IMAGING. The owner is based in Charlotte, NC.
1927 S. Tryon Sreet
Suite 200
Charlotte, NC 28203
Showing of trademarks Trademarks
Trademark Classifications
LEAD TECHNOLOGIES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does LEAD TECHNOLOGIES, INC. have?
LEAD TECHNOLOGIES, INC. has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned, 2 cancelled.
What trademark classes does LEAD TECHNOLOGIES, INC. file in?
LEAD TECHNOLOGIES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are LEAD TECHNOLOGIES, INC.'s most well-known trademarks?
LEAD TECHNOLOGIES, INC.'s registered trademark portfolio includes well-known marks such as LEAD, MIPACS, LEADVIEW, LEADTOOLS, and MEDICOR IMAGING. These are among 5 currently registered trademarks in the portfolio.
What is LEAD TECHNOLOGIES, INC.'s trademark registration success rate?
LEAD TECHNOLOGIES, INC. has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.